ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
about
Repeated recruitment of LTR retrotransposons as promoters by the anti-apoptotic locus NAIP during mammalian evolutionSMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP)IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition.Research progress on Livin protein: an inhibitor of apoptosisLivin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathwayCaspases: pharmacological manipulation of cell deathInhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs.Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cellsProteolytic cleavage of Livin (ML-IAP) in apoptotic melanoma cells potentially mediated by a non-canonical caspaseHuman inhibitor of apoptosis proteins: why XIAP is the black sheep of the familyTargeting Cell Survival Proteins for Cancer Cell DeathOncostatic-Cytoprotective Effect of Melatonin and Other Bioactive Molecules: A Common Target in Mitochondrial RespirationCurrent status and prospect of lung cancer gene therapyPlasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysisDiscovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells.Dormancy of growth-stunted malignant melanoma: sustainable and smoldering patternsTwo splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution patternILPIP, a novel anti-apoptotic protein that enhances XIAP-mediated activation of JNK1 and protection against apoptosisExpression of BIRC7 protein and mRNA in non-Hodgkin's lymphomaSmall molecules destabilize cIAP1 by activating auto-ubiquitylationExpedient synthesis of highly potent antagonists of inhibitor of apoptosis proteins (IAPs) with unique selectivity for ML-IAPRecruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexesUp-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanismsMolecular mechanisms of caspase regulation during apoptosisMelanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction.An unconventional IAP-binding motif revealed by target-assisted iterative screening (TAIS) of the BIR3-cIAP1 domain.Characterization of XIAP-deficient mice.Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins.Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublinesThe role of E3 ligases in the ubiquitin-dependent regulation of spermatogenesisOvercoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)Antisense oligonucleotide targeting Livin induces apoptosis of human bladder cancer cell via a mechanism involving caspase 3.Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundancecIAP1 cooperatively inhibits procaspase-3 activation by the caspase-9 apoptosomeApoptosis and its clinical impact.The domains of apoptosis: a genomics perspective.Selectively frequent expression of CXCR5 enhances resistance to apoptosis in CD8(+)CD34(+) T cells from patients with T-cell-lineage acute lymphocytic leukemia.Inhibitor of apoptosis protein-like protein-2 as a novel serological biomarker for breast cancer.Induction of apoptosis in cancer: new therapeutic opportunities.
P2860
Q21563460-26922AB2-95EE-4E8A-A89F-519534B757A0Q24292189-2386DDDB-6DE6-49B4-91A3-88CA4BE8D17BQ24292370-AB14BC70-D2F8-4F10-A93F-AACBF13C7A78Q24304472-C190708F-1E9B-4AF0-B6D5-BE1B31C76B87Q24338158-27C56B70-AE22-4F03-89D1-D880B3E05018Q24536096-6128A320-FE47-4092-8E27-E89AC37A2EA9Q24544173-821CE21D-B7D2-4494-A9AB-BB46BF5DE481Q24602706-0312A2A8-5D67-4BD0-AAEA-300672224058Q24656141-CB209ED3-5AC2-4FE9-B031-13C9ADF0BA55Q24670396-E7B0D22E-12BC-462C-9789-76F8E658C546Q26765447-5B5B22C2-A857-4942-BDD5-3C00FD00C17DQ26766876-F49577BE-B6A0-4ED6-9E39-B2C1C91C7AABQ26825190-D2CC5DE0-3AA9-4072-A0D7-714B5737D0F8Q27647196-DCC37E74-9C5F-4FEC-A3C2-34F2E4F6BFFEQ27678027-B867F6D8-50FF-4F66-B490-8AAA7E406B68Q27851964-4E439AD2-64F2-43E6-9BB9-445F119F8351Q28083204-D04B22FA-CEEF-4631-8F17-203221B9E923Q28185610-75F3018C-B923-4662-8E95-0A7B9C8B113AQ28202543-B9B2B7DC-AD8D-48BC-B644-695EE4895DE6Q28251881-FFD9B7D1-4C1D-4BB6-9A89-7AFDFABF07C2Q28266432-601948C5-96B1-4217-912B-4EA351720F2FQ28283505-64179965-7340-487E-852F-D234C96C6C32Q28354545-20289122-1255-4CF5-803F-96FC01A26779Q28361631-406AC966-68A1-4F0B-929E-1F0D48F8E6EAQ29617861-810F31A9-B8C4-4A3B-830B-5D28CF1899A7Q30894063-330DFB3F-6658-42E9-AEBE-9130E567C038Q33263114-628B3210-77D2-4B76-B61B-9026B9AE1C9AQ33559119-33995D98-100C-4F2D-BCCC-D20DAC9C1F59Q33632016-9386EADE-4E89-4C9F-A239-E0461392C9A3Q33646953-9E156BDB-C419-4890-A83E-BDFCC8C09B5FQ33707078-9593F1DC-69F7-4C90-BCB7-E5226B545D5BQ33841579-6C0E498E-F666-4EE5-A88F-C345552468E2Q33933676-91411F33-B4B6-4827-85FA-0074DD2A5217Q34132152-1A627BBD-1868-4FD8-86D8-602AE4663361Q34144567-505D988C-AAE9-4E14-B257-EC837773C281Q34214558-76819422-C1E1-49AD-A785-DB00A68FB5CFQ34330221-8CD04D2E-B65F-4169-990F-B50824D7052CQ34373668-6D9C63E1-7D69-4BD0-81C3-85226ACDE1FCQ34504130-40576AD5-6C37-486B-BACC-E1202662EA03Q35043420-52E2280A-0AE9-46DB-B1C2-820330887D2F
P2860
ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
ML-IAP, a novel inhibitor of a ...... y expressed in human melanomas
@ast
ML-IAP, a novel inhibitor of a ...... y expressed in human melanomas
@en
ML-IAP, a novel inhibitor of a ...... y expressed in human melanomas
@en-gb
ML-IAP, a novel inhibitor of a ...... y expressed in human melanomas
@nl
type
label
ML-IAP, a novel inhibitor of a ...... y expressed in human melanomas
@ast
ML-IAP, a novel inhibitor of a ...... y expressed in human melanomas
@en
ML-IAP, a novel inhibitor of a ...... y expressed in human melanomas
@en-gb
ML-IAP, a novel inhibitor of a ...... y expressed in human melanomas
@nl
prefLabel
ML-IAP, a novel inhibitor of a ...... y expressed in human melanomas
@ast
ML-IAP, a novel inhibitor of a ...... y expressed in human melanomas
@en
ML-IAP, a novel inhibitor of a ...... y expressed in human melanomas
@en-gb
ML-IAP, a novel inhibitor of a ...... y expressed in human melanomas
@nl
P2093
P1433
P1476
ML-IAP, a novel inhibitor of a ...... y expressed in human melanomas
@en
P2093
G S Salvesen
H R Stennicke
M T Pisabarro
P304
P356
10.1016/S0960-9822(00)00781-8
P407
P577
2000-11-02T00:00:00Z